<p>Symptoms, Management and Healthcare Utilization of COPD Patients During the COVID-19 Epidemic in Beijing</p>

• DOI: 10.2147/copd.s270448
• Publication Date: 2020-10-13T21:52:55Z
• Authors: Ying Liang; Chun Chang; Yahong Chen; Fawu Dong; Linlin Zhang; Yongchang Sun
• Keywords: Male; Pneumonia, Viral; International Journal of Chronic Obstructive Pulmonary Disease; Health Services Accessibility; chronic obstructive pulmonary disease; Diseases of the respiratory system; Betacoronavirus; Pulmonary Disease, Chronic Obstructive; 03 medical and health sciences; exacerbation; 0302 clinical medicine; Humans; Pandemics; Original Research; Aged; Aged, 80 and over; RC705-779; SARS-CoV-2; Self-Management; COVID-19; Middle Aged; Patient Acceptance of Health Care; 3. Good health; Cross-Sectional Studies; covid-19; Beijing; Female; Coronavirus Infections; management

Background: Social distancing and restriction measures during the COVID-19 epidemic may have impacts on medication availability healthcare utilization for COPD patients, thereby affect standard disease management. We aimed to investigate change of respiratory symptoms, pharmacological treatment patients in Beijing, China. Methods: conducted a single-center, cross-sectional survey performed at Peking University Third Hospital recruited with who were interviewed by phone call. Clinical data, including treatment, management access before from January 25 April 25, 2020, collected. Results: A total 153 enrolled analysis. Before epidemic, 81.7% (125/153) had long-term maintenance ICS/LABA (60.8%) LAMA (57.5%) most commonly used. During 75.2% (115/153) maintained their 6.5% (10/153) reduce or stop taking medications, slight decrease (53.6%) (56.9%). Most [76.5% (117/153)] low symptom burden, CAT score < 10 epidemic. Of 45 (29.4%) reported worsening symptoms but only 15.6% (7/45) sought medical care hospitals, while remaining expressed concerns about cross-infection hospital (55.5%, 25/45) mild which managed themselves (28.8%, 13/45). Conclusion: our mild-to-moderate symptoms. Approximately, 30.0% experienced them did not seek due cross-infection. Keywords: COVID-19, chronic obstructive pulmonary disease, exacerbation,